MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/copd.s617958

Медицинская библиотека · International journal of chronic obstructive pulmonary disease · 2026

Irisin, BMI, and SII as Predictors of Frequent Acute Exacerbations in COPD: Development of a Predictive Nomogram.

Bai Zina, Sun Tongxinwei, Song Wenhui, Zhang Zhiwei, Li Jing, Wu Siyu, Wang Zheng, Meng Aihong

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

Frequent acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with poor prognosis, but objective and easily applicable predictors remain limited. This study aimed to investigate the association of Irisin, body mass index (BMI), and systemic immune-inflammation index (SII) with frequent acute exacerbations in COPD and to develop a predictive nomogram.

METHODS

This single-center retrospective-prospective observational study included 96 patients hospitalized with acute exacerbation of COPD (AECOPD) between March 2023 and March 2025. Frequent exacerbation was defined as ≥2 acute exacerbations or ≥1 hospitalization for AECOPD within one year. Patients were classified into the frequent exacerbation group (n=34) and non-frequent exacerbation group (n=62). Clinical data and serum Irisin levels were collected. Group comparisons, correlation analysis, univariate and multivariable logistic regression analyses were performed, and a nomogram was developed. Model performance was evaluated using receiver operating characteristic (ROC) analysis, calibration curve, bootstrap internal validation, and decision curve analysis.

RESULTS

Compared with the non-frequent exacerbation group, the frequent exacerbation group had lower Irisin and BMI levels and higher white blood cell count, neutrophil count, and SII. Multivariable logistic regression showed that Irisin (OR=0.981, 95% CI: 0.974-0.989) and BMI (OR=0.980, 95% CI: 0.963-0.998) were independently associated with a lower risk of frequent exacerbations, whereas lnSII (OR=1.117, 95% CI: 1.012-1.234) was associated with a higher risk. The combined model yielded an area under the ROC curve of 0.856 (95% CI: 0.780-0.933), showing better discrimination than Irisin alone. Calibration and decision curve analyses suggested favorable internal performance.

CONCLUSION

Irisin, BMI, and SII were associated with frequent acute exacerbations in COPD. The combined nomogram may provide a preliminary reference for risk stratification, but external validation is required before clinical application.

Для цитирования: Bai Zina, Sun Tongxinwei, Song Wenhui, Zhang Zhiwei, Li Jing, Wu Siyu, Wang Zheng, Meng Aihong. Irisin, BMI, and SII as Predictors of Frequent Acute Exacerbations in COPD: Development of a Predictive Nomogram.. International journal of chronic obstructive pulmonary disease. 2026. DOI: 10.2147/copd.s617958.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.